Virological response and safety outcomes in therapy-naïve patients treated for chronic hepatitis C with taribavirin or ribavirin in combination with pegylated interferon alfa-2a: A randomized, phase 2 study

Given with interferon, taribavirin produced SVR rates comparable to those of ribavirin, with a lower occurrence of anemia.